Results

eNauka >  Results >  PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial
Title: PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial
Authors: Chia Stephen K. L.; Miguel Martin; Holmes Frankie A.; Ejlertsen Bent; Delaloge Suzette; Moy Beverly; Iwata Hiroji; von Minckwitz Gunter; Mansi Janine; Barrios Carlos H;
Gnant Michael; Tomašević Zorica; Denduluri Neelima; Šeparović Robert; Kim Sung-Bae; Jakobsen Erik Hugger; Harvey Vernon; Robert Nicholas; Smith II John; Harker Graydon; Zhang Bo; Eli Lisa D; Ye Yining; Lalani Alshad S; Buyse Marc; Chan Arlene;
Issue Date: 2019
Publication: Breast Cancer Res 21(1) 39
ISSN: 1465-542X Breast Cancer Research Search Idenfier
Type: Article
Collation: vol. 21 br. 1
DOI: 10.1186/s13058-019-1115-2
WoS-ID: 000461337400001
Scopus-ID: 2-s2.0-85062890379
PMID: 30867034
PMCID: PMC6417207
URI: https://zenodo.org/record/4474850
https://enauka.gov.rs/handle/123456789/597531
Project: url:https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-019-1115-2
M-category: 
21aM21a

21
SCOPUSTM
14
PubMed CentralTM
12
OpenCitations
21
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.